The most important financial indicators for the company Dux Md Pharma Solutions S.r.l. - Unique Identification Number 34490250:
sales in 2023 was
632.681
euro, registering a net profit of
21.789
euro and having an average number of
7
employees.
Firma isi desfasoara activitatea in domeniul Comert cu ridicata al produselor farmaceutice having the NACE code 4646.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 10.6%, from 573.987 euro in the year 2022, to 632.681 euro in 2023.
The Net Profit increased by 1.496 euro, from 20.355 euro in 2022, to 21.789 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Dux Md Pharma Solutions S.r.l. - CUI 34490250
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
-
0
76
127
0
8.422
5.711
3.221
1.497
5.549
Current Assets
-
89
22.556
28.771
56.397
119.437
194.378
219.310
238.906
209.084
Inventories
-
7
9.448
12.970
17.859
42.556
88.741
77.911
63.065
90.814
Receivables
-
0
2.853
5.620
6.581
8.155
21.829
39.853
55.534
61.022
Cash
-
82
10.255
10.181
31.957
68.726
83.808
101.547
120.307
57.248
Shareholders Funds
-
-380
-11.950
-6.181
33.335
69.067
111.985
180.299
21.009
20.111
Social Capital
-
45
45
44
43
42
41
40
41
40
Debts
-
469
34.583
35.121
23.231
59.728
89.282
43.449
221.209
196.510
Income in Advance
-
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
209.084 euro in 2023 which includes Inventories of
90.814 euro, Receivables of
61.022 euro and cash availability of
57.248 euro.
The company's Equity was valued at
20.111 euro, while total Liabilities amounted to
196.510 euro.
Equity decreased by -834 euro, from 21.009 euro in 2022, to 20.111 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Dux Md Pharma Solutions S.r.l.